Anxiety
- PMID: 27349358
- DOI: 10.1016/S0140-6736(16)30381-6
Anxiety
Abstract
Anxiety disorders (separation anxiety disorder, selective mutism, specific phobias, social anxiety disorder, panic disorder, agoraphobia, and generalised anxiety disorder) are common and disabling conditions that mostly begin during childhood, adolescence, and early adulthood. They differ from developmentally normative or stress-induced transient anxiety by being marked (ie, out of proportion to the actual threat present) and persistent, and by impairing daily functioning. Most anxiety disorders affect almost twice as many women as men. They often co-occur with major depression, alcohol and other substance-use disorders, and personality disorders. Differential diagnosis from physical conditions-including thyroid, cardiac, and respiratory disorders, and substance intoxication and withdrawal-is imperative. If untreated, anxiety disorders tend to recur chronically. Psychological treatments, particularly cognitive behavioural therapy, and pharmacological treatments, particularly selective serotonin-reuptake inhibitors and serotonin-noradrenaline-reuptake inhibitors, are effective, and their combination could be more effective than is treatment with either individually. More research is needed to increase access to and to develop personalised treatments.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.Health Technol Assess. 2017 Aug;21(45):1-138. doi: 10.3310/hta21450. Health Technol Assess. 2017. PMID: 28853392 Free PMC article. Clinical Trial.
-
Anxiety Disorders: A Review.JAMA. 2022 Dec 27;328(24):2431-2445. doi: 10.1001/jama.2022.22744. JAMA. 2022. PMID: 36573969 Review.
-
Current and Novel Psychopharmacological Drugs for Anxiety Disorders.Adv Exp Med Biol. 2020;1191:347-365. doi: 10.1007/978-981-32-9705-0_19. Adv Exp Med Biol. 2020. PMID: 32002937 Review.
-
Overview of diagnosis and drug treatments of anxiety disorders.CNS Spectr. 2005 Jan;10(1):49-56. doi: 10.1017/s1092852900009901. CNS Spectr. 2005. PMID: 15618947 Review.
-
Assessment and management of anxiety disorders in children and adolescents.Arch Dis Child. 2014 Jul;99(7):674-8. doi: 10.1136/archdischild-2013-303768. Epub 2014 Mar 17. Arch Dis Child. 2014. PMID: 24636957 Free PMC article. Review.
Cited by
-
Obeticholic Acid Inhibits Anxiety via Alleviating Gut Microbiota-Mediated Microglia Accumulation in the Brain of High-Fat High-Sugar Diet Mice.Nutrients. 2021 Mar 15;13(3):940. doi: 10.3390/nu13030940. Nutrients. 2021. PMID: 33803974 Free PMC article.
-
Preoperative Anxiety in Chinese Adult Patients Undergoing Elective Surgeries: A Multicenter Cross-Sectional Study.World J Surg. 2022 Dec;46(12):2927-2938. doi: 10.1007/s00268-022-06720-9. Epub 2022 Sep 7. World J Surg. 2022. PMID: 36070012 Free PMC article.
-
Effectiveness of electroacupuncture on anxiety: a systematic review and meta-analysis of randomized controlled trials.Front Psychol. 2023 Dec 19;14:1196177. doi: 10.3389/fpsyg.2023.1196177. eCollection 2023. Front Psychol. 2023. PMID: 38173848 Free PMC article.
-
Neuroprotective Roles of Apelin-13 in Neurological Diseases.Neurochem Res. 2023 Jun;48(6):1648-1662. doi: 10.1007/s11064-023-03869-0. Epub 2023 Feb 6. Neurochem Res. 2023. PMID: 36745269 Review.
-
Anxiety Specific Response and Contribution of Active Hippocampal Neural Stem Cells to Chronic Pain Through Wnt/β-Catenin Signaling in Mice.Front Mol Neurosci. 2018 Aug 24;11:296. doi: 10.3389/fnmol.2018.00296. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30197587 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical